Xstrahl has just returned from Milan, Italy, where it joined other leading system and software manufacturers to showcase the latest advances in radiation oncology at the annual European Society for Radiotherapy & meeting. This year’s show theme was targeting...
PURPOSE: The goal of this work was to develop and test a cylindrical tissue-equivalent quality assurance (QA) phantom for micro computed tomography (microCT) image-guided small animal irradiators that overcomes deficiencies of existing phantoms due to its mouse-like...
Xstrahl is attending the 5th annual Preclinical Imaging Consortium taking place on 28 – 30 April 2019 at Northwestern University, Evanston, IL. The event’s agenda this year features presentations of scholars from the US leading universities on the following topics:...
April 24th, 2019 New 150kV superficial treatment system spotlighted on Xstrahl booth (No. 3420) at ESTRO show in Milan, Italy, April 26th-29th Xstrahl Medical, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological...
Over the years, many in vitro and in vivo studies have shown the antineoplastic effects of cannabinoids (CBDs), with reports advocating for investigations of combination therapy approaches that could better leverage these effects in clinical translation. This study...
April 24th, 2019 New 150kV superficial treatment system and SARRP research platform among advanced solutions showcased on Xstrahl booth (No. 3420) at European Society for Radiotherapy & Oncology annual meeting in Milan, April 26th-29th Xstrahl Medical, global...
Xstrahl has just returned from the Nevskiy Radiology Forum which took place in St.-Petersburg, Russia on the 12th – 13th of April. The Nevskiy Forum is an established platform gathering together radiologists, ultrasound specialists, and radiation therapists to share...
The extent of tumor oxygenation is an important factor contributing to the efficacy of radiation therapy. Several preclinical studies have shown benefit of combining radiation therapy with drugs that inhibit tumor blood vessel growth, i.e. angiostatic therapy. Recent...
Current treatment methods for arteriovenous malformation (AVM) are surgery and radiosurgery. However, complete occlusion post radiosurgery is achieved within 3 years, while patient remain at risk of haemorrhage. Therefore is important to develop a new molecular...
Contact Us